An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes

被引:44
作者
Kang, W. [1 ]
Wang, L. [1 ]
Harrell, H. [1 ]
Liu, J. [1 ]
Thomas, D. L. [1 ]
Mayfield, T. L. [1 ]
Scotti, M. M. [1 ]
Ye, G. J. [1 ]
Veres, G. [1 ]
Knop, D. R. [1 ]
机构
[1] Appl Genet Technol Corp, Alachua, FL 32615 USA
关键词
adeno-associated virus; herpes simplex virus; viral vector; co-infection; scalable rAAV production; HERPES-SIMPLEX-VIRUS; ADENO-ASSOCIATED VIRUS; MEDIATED GENE-TRANSFER; ADENOASSOCIATED VIRUS; REP GENE; CELL-LINES; FACTOR-IX; EXPRESSION; AAV; TYPE-1;
D O I
10.1038/gt.2008.158
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recombinant herpes simplex virus type 1 (rHSV)-assisted recombinant adeno-associated virus (rAAV) vector production provides a highly efficient and scalable method for manufacture of clinical grade rAAV vectors. Here, we present an rHSV co-infection system for rAAV production, which uses two ICP27-deficient rHSV constructs, one bearing the rep2 and cap (1, 2 or 9) genes of rAAV, and the second bearing an AAV2 ITR-gene of interest (GOI) cassette. The optimum rAAV production parameters were defined by producing rAAV2/GFP in HEK293 cells, yielding greater than 9000 infectious particles per cell with a 14: 1 DNase resistance particle to infectious particle (DRP/ip) ratio. The optimized co-infection parameters were then used to generate large-scale stocks of rAAV1/AAT, which encode the human alpha-1-antitrypsin (hAAT) protein, and purified by column chromatography. The purified vector was extensively characterized by rAAV- and rHSV-specific assays and compared to transfection-made vector for in vivo efficacy in mice through intramuscular injection. The co-infection method was also used to produce rAAV9/AAT for comparison to rAAV1/AAT in vivo. Intramuscular administration of 1 x 10(11) DRP per animal of rHSV-produced rAAV1/AAT and rAAV9/AAT resulted in hAAT protein expression of 5.4 x 10(4) and 9.4 x 10(5) ng ml(-1) serum respectively, the latter being clinically relevant.
引用
收藏
页码:229 / 239
页数:11
相关论文
共 59 条
[51]   Insect cells as a factory to produce adeno-associated virus type 2 vectors [J].
Urabe, M ;
Ding, CT ;
Kotin, RM .
HUMAN GENE THERAPY, 2002, 13 (16) :1935-1943
[52]   A SUBSET OF HERPES-SIMPLEX VIRUS-REPLICATION GENES PROVIDES HELPER FUNCTIONS FOR PRODUCTIVE ADENOASSOCIATED VIRUS-REPLICATION [J].
WEINDLER, FW ;
HEILBRONN, R .
JOURNAL OF VIROLOGY, 1991, 65 (05) :2476-2483
[53]   Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA [J].
Worgall, Stefan ;
Sondhi, Dolan ;
Hackett, Neil R. ;
Kosofsky, Barry ;
Kekatpure, Minal V. ;
Neyzi, Nurunisa ;
Dyke, Jonathan P. ;
Ballon, Douglas ;
Heier, Linda ;
Greenwald, Bruce M. ;
Christos, Paul ;
Mazumdar, Madhu ;
Souweidane, Mark M. ;
Kaplitt, Michael G. ;
Crystal, Ronald G. .
HUMAN GENE THERAPY, 2008, 19 (05) :463-474
[54]   Production of recombinant adeno-associated type 5 (rAAV5) vectors using recombinant herpes simplex viruses containing rep and cap [J].
Wustner, JT ;
Arnold, S ;
Lock, M ;
Richardson, JC ;
Himes, VB ;
Kurtzman, G ;
Peluso, RW .
MOLECULAR THERAPY, 2002, 6 (04) :510-518
[55]   Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus [J].
Xiao, X ;
Li, J ;
Samulski, RJ .
JOURNAL OF VIROLOGY, 1998, 72 (03) :2224-2232
[56]   A Novel Herpes Simplex Virus Helper Based Production of Adeno-Associated Virus Vectors for Treatment of Retinal Angiogenesis [J].
Ye, Guo-jie ;
Drogemuller, Chris ;
Thomas, Darby ;
Scotti, Marina ;
Kang, Wen ;
Knop, David ;
Boye, Sanford ;
Pechan, Peter ;
Peterson, James ;
Hauswirth, William ;
Scaria, Abraham ;
Wadsworth, Samuel .
MOLECULAR THERAPY, 2006, 13 :S194-S194
[57]   High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H [J].
Zhang, XL ;
de Alwis, M ;
Hart, SL ;
Fitzke, FW ;
Inglis, SC ;
Boursnell, MEG ;
Levinsky, RJ ;
Kinnon, C ;
Ali, RR ;
Thrasher, AJ .
HUMAN GENE THERAPY, 1999, 10 (15) :2527-2537
[58]   Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield [J].
Zolotukhin, S ;
Byrne, BJ ;
Mason, E ;
Zolotukhin, I ;
Potter, M ;
Chesnut, K ;
Summerford, C ;
Samulski, RJ ;
Muzyczka, N .
GENE THERAPY, 1999, 6 (06) :973-985
[59]   Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors [J].
Zolotukhin, S ;
Potter, M ;
Zolotukhin, I ;
Sakai, Y ;
Loiler, S ;
Fraites, TJ ;
Chiodo, VA ;
Phillipsberg, T ;
Muzyczka, N ;
Hauswirth, WW ;
Flotte, TR ;
Byrne, BJ ;
Snyder, RO .
METHODS, 2002, 28 (02) :158-167